THE CHALLENGE
Using MongoDB Atlas on AWS to scale patient monitoring for BioIntelliSense
BioIntelliSense is ushering in a new era of continuous health monitoring. The medical technology company’s BioButton® wearable device captures vital signs and physiological biometrics, helping clinicians provide proactive patient care through advanced monitoring and early detection. The solution consists of three integrated components: the BioButton device, which collects patient data; the BioCloud™ platform, which ingests and processes that data; and the BioDashboard™ clinical interface, where healthcare providers monitor and analyze patient information.
The first version of the BioDashboard interface was built on a third-party application using SQL Server. However, the database architecture was reaching its scalability limits and becoming increasingly difficult to maintain. “Our previous SQL Server–based system couldn’t scale with the growth expected from our business,” said Tim Posey, Senior Director of Clinical Applications at BioIntelliSense.
Because the solution monitors patient vital signs and generates notifications of potential medical conditions, unplanned downtime wasn’t an option. In 2023, the stakes became even higher as the BioButton system gained market traction and patient volumes increased dramatically.
The BioDashboard interface needed to scale seamlessly to support tens of thousands of concurrent patients while maintaining consistent performance for both data ingestion from devices and access by clinicians. Given the sensitive nature of patient health data, the platform also required enterprise-grade security and compliance capabilities.
BioIntelliSense chose MongoDB Atlas on Amazon Web Services (AWS) as the foundation for the BioDashboard interface. The scalability of AWS, combined with MongoDB’s developer-friendly approach and robust support for Internet of Things workloads, made MongoDB Atlas on AWS the clear choice.

